Q3 2024 |
102 |
$4.66B |
+$695M |
-$898M |
-$202M |
ACLX, NUVL, FOLD, IOVA, PCVX
|
13F-HR |
11/14/2024, 04:10 PM |
Q2 2024 |
107 |
$4.14B |
+$409M |
-$1.11B |
-$706M |
CERE, FOLD, ACLX, IOVA, NUVL
|
Restatement |
8/16/2024, 04:10 PM |
Q1 2024 |
105 |
$5.67B |
+$1.46B |
-$627M |
+$835M |
CERE, FOLD, IOVA, ACLX, NUVL
|
Restatement |
8/6/2024, 05:06 PM |
Q4 2023 |
97 |
$4.47B |
+$885M |
-$394M |
+$491M |
CERE, FOLD, LIANY, ACLX, NUVL
|
Restatement |
2/23/2024, 07:00 PM |
Q3 2023 |
87 |
$2.97B |
+$386M |
-$544M |
-$158M |
FOLD, CERE, IMVT, ACLX, NUVL
|
13F-HR |
11/14/2023, 04:14 PM |
Q2 2023 |
88 |
$3.44B |
+$654M |
-$846M |
-$193M |
FOLD, CERE, LIANY, ACLX, AMLX
|
Restatement |
8/24/2023, 04:10 PM |
Q1 2023 |
98 |
$3.38B |
+$682M |
-$490M |
+$193M |
FOLD, RETA, AMLX, CERE, MDGL
|
Restatement |
5/16/2023, 03:29 PM |
Q4 2022 |
94 |
$3.47B |
+$622M |
-$743M |
-$121M |
FOLD, AMLX, MDGL, CERE, RXDX
|
13F-HR |
2/14/2023, 04:18 PM |
Q3 2022 |
115 |
$3.44B |
+$595M |
-$334M |
+$261M |
FOLD, MRTX, CERE, GBT, AMLX
|
13F-HR |
11/14/2022, 04:24 PM |
Q2 2022 |
109 |
$2.7B |
+$281M |
-$811M |
-$530M |
FOLD, MRTX, CERE, IOVA, LIANY
|
13F-HR |
8/15/2022, 04:49 PM |
Q1 2022 |
135 |
$4.19B |
+$394M |
-$672M |
-$278M |
FOLD, SWTX, LIANY, IOVA, MRTX
|
13F-HR |
5/16/2022, 04:31 PM |
Q4 2021 |
145 |
$5.65B |
$0 |
$0 |
|
MRTX, LIANY, FOLD, SWTX, IOVA
|
New Holdings |
5/4/2022, 10:18 AM |
Q4 2021 |
145 |
$5.65B |
+$973M |
-$583M |
+$390M |
MRTX, LIANY, FOLD, SWTX, IOVA
|
Restatement |
4/13/2022, 04:24 PM |
Q3 2021 |
138 |
$6.04B |
+$585M |
-$876M |
-$290M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
Restatement |
12/3/2021, 03:34 PM |
Q2 2021 |
148 |
$6.9B |
$0 |
$0 |
|
MRTX, BBIO, SWTX, IOVA, FOLD
|
New Holdings |
8/17/2021, 09:17 AM |
Q2 2021 |
148 |
$6.9B |
+$965M |
-$605M |
+$360M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
13F-HR |
8/16/2021, 04:36 PM |
Q1 2021 |
136 |
$6.72B |
+$918M |
-$1.46B |
-$542M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
Restatement |
8/13/2021, 05:01 PM |
Q4 2020 |
137 |
$8.49B |
+$2.04B |
-$763M |
+$1.27B |
MRTX, FOLD, BBIO, IOVA, NVTAQ
|
13F-HR |
2/16/2021, 04:32 PM |
Q3 2020 |
123 |
$5.87B |
+$1.14B |
-$823M |
+$317M |
MRTX, FOLD, IOVA, GBT, BBIO
|
13F-HR |
11/16/2020, 04:35 PM |
Q2 2020 |
123 |
$5.27B |
+$795M |
-$472M |
+$323M |
FOLD, GBT, IOVA, MRTX, NBIX
|
Restatement |
8/17/2020, 11:00 AM |
Q1 2020 |
110 |
$3.83B |
+$491M |
-$493M |
-$2.06M |
IOVA, GBT, NBIX, MRTX, FOLD
|
Restatement |
5/18/2020, 12:10 PM |
Q4 2019 |
110 |
$4.86B |
+$465M |
-$522M |
-$57.9M |
GBT, MRTX, NBIX, KOD, IOVA
|
Restatement |
2/19/2020, 05:03 PM |
Q3 2019 |
104 |
$3.66B |
+$365M |
-$397M |
-$32.4M |
NBIX, GBT, MRTX, IOVA, FOLD
|
13F-HR |
11/14/2019, 04:50 PM |
Q2 2019 |
101 |
$4.33B |
+$903M |
-$443M |
+$460M |
NBIX, GBT, MRTX, IOVA, FOLD
|
13F-HR |
8/14/2019, 05:18 PM |
Q1 2019 |
96 |
$3.54B |
+$583M |
-$413M |
+$171M |
NBIX, FOLD, GBT, ZGNX, AMRN
|
Restatement |
5/15/2019, 07:52 PM |
Q4 2018 |
98 |
$2.53B |
+$541M |
-$724M |
-$183M |
NBIX, GBT, FOLD, ZGNX, IOVA
|
13F-HR |
2/14/2019, 04:30 PM |
Q3 2018 |
114 |
$3.68B |
+$470M |
-$603M |
-$134M |
NBIX, FOLD, GBT, ZGNX, ALNY
|
13F-HR |
11/14/2018, 05:00 PM |
Q2 2018 |
126 |
$3.73B |
+$518M |
-$565M |
-$47.1M |
NBIX, FOLD, GBT, ALNY, ZGNX
|
Restatement |
11/1/2018, 05:16 PM |
Q1 2018 |
128 |
$3.56B |
+$727M |
-$383M |
+$344M |
NBIX, FOLD, GBT, ZGNX, ALNY
|
13F-HR |
5/15/2018, 04:19 PM |
Q4 2017 |
129 |
$3.02B |
+$567M |
-$326M |
+$240M |
NBIX, FOLD, GBT, ALNY, ZGNX
|
13F-HR |
2/14/2018, 05:59 PM |
Q3 2017 |
131 |
$2.59B |
+$441M |
-$213M |
+$228M |
NBIX, FOLD, ALNY, GBT, ZGNX
|
Restatement |
11/14/2017, 05:20 PM |
Q2 2017 |
120 |
$1.84B |
+$434M |
-$311M |
+$123M |
FOLD, NBIX, ALNY, GBT, LJPC
|
13F-HR |
8/14/2017, 04:33 PM |
Q1 2017 |
158 |
$1.75B |
+$389M |
-$281M |
+$108M |
NBIX, GBT, FOLD, VSAR, LJPC
|
13F-HR |
5/15/2017, 04:36 PM |
Q4 2016 |
172 |
$1.4B |
+$309M |
-$221M |
+$88M |
NBIX, TSRO, FOLD, SRPT, VSAR
|
Restatement |
5/2/2017, 04:31 PM |
Q3 2016 |
187 |
$1.54B |
+$270M |
-$341M |
-$71M |
SRPT, NBIX, FOLD, TSRO, RTRX
|
13F-HR |
11/14/2016, 04:36 PM |
Q2 2016 |
162 |
$1.22B |
+$224M |
-$207M |
+$16.5M |
NBIX, TSRO, FOLD, SRPT, RTRX
|
13F-HR |
8/11/2016, 02:38 PM |
Q1 2016 |
164 |
$1.11B |
+$280M |
-$155M |
+$125M |
FOLD, NBIX, SRPT, TSRO, AGN
|
13F-HR |
5/16/2016, 04:32 PM |
Q4 2015 |
151 |
$1.3B |
+$205M |
-$150M |
+$54.5M |
FOLD, NBIX, SRPT, DYAX, TSRO
|
13F-HR |
2/16/2016, 04:59 PM |
Q3 2015 |
142 |
$1.09B |
$0 |
$0 |
|
FOLD, NBIX, SRPT, RTRX, TSRO
|
New Holdings |
11/17/2015, 10:11 AM |
Q3 2015 |
142 |
$1.09B |
+$177M |
-$301M |
-$123M |
FOLD, NBIX, SRPT, RTRX, TSRO
|
13F-HR |
11/16/2015, 04:30 PM |
Q2 2015 |
162 |
$1.51B |
+$292M |
-$219M |
+$72.8M |
FOLD, NBIX, RTRX, SRPT, TSRO
|
13F-HR |
8/14/2015, 04:31 PM |
Q1 2015 |
147 |
$1.25B |
+$264M |
-$329M |
-$65.1M |
FOLD, NBIX, RTRX, TSRO, RLYP
|
13F-HR |
5/15/2015, 04:31 PM |
Q4 2014 |
137 |
$1.11B |
+$305M |
-$214M |
+$90.8M |
FOLD, NBIX, ACRX, SRPT, RLYP
|
13F-HR |
2/17/2015, 04:01 PM |
Q3 2014 |
115 |
$841M |
+$168M |
-$277M |
-$109M |
FOLD, NBIX, SRPT, ACRX, CELG
|
Restatement |
11/17/2014, 12:30 PM |
Q2 2014 |
109 |
$995M |
+$318M |
-$190M |
+$129M |
SRPT, NBIX, ACRX, VRTX, CELG
|
13F-HR |
8/14/2014, 04:00 PM |
Q1 2014 |
116 |
$891M |
+$281M |
-$277M |
+$3.6M |
ACRX, NBIX, SRPT, VRTX, TSRO
|
13F-HR |
5/15/2014, 04:00 PM |
Q4 2013 |
100 |
$808M |
$0 |
$0 |
|
CELG, ACRX, SRPT, VRTX, TSRO
|
13F-HR |
2/14/2014, 04:33 PM |